BELLASAFE M

Dual Action, Total Allergy Control

10x10 Tablets

Pharma

Anti-Allergic

Product highlights

Perfect synergy of antihistamine & anti-leukotriene
Non-sedating antihistaminic action
Rapid onset with prolonged duration of relief
Comprehensive relief from allergic symptoms
Improved quality of life compared to monotherapy

BELLASAFE M combines Bilastine 20mg and Montelukast 10mg to provide effective control of allergic conditions with dual-action antihistamine and anti-leukotriene therapy.

Dosage Form

Tablet

Product Name

BELLASAFE M

Composition

Bilastine 20mg + Montelukast 10mg

Therapeutic Segment

Anti-allergic / Antihistamine

Pharmacological Action

Selective H1 antihistaminic with anti-leukotriene action for comprehensive allergy management

Mechanism

Bilastine blocks H1 histamine receptors reducing allergic symptoms, while Montelukast inhibits leukotriene receptors to reduce airway inflammation and allergic responses.

Key Clinical Benefits

Non-sedating antihistaminic action
Rapid onset and prolonged duration of action
Effective control of allergic symptoms
Improved patient quality of life
Better safety and efficacy profile

Key Indications

Asthma
Nasal allergies
Urticaria
Respiratory allergies
Allergic rhinitis

Administration

To be taken on an empty stomach and 1 hour before meals

Recommended Usage

1 tablet once daily or as directed by the physician

Dosage Form

Tablet

Product Name

BELLASAFE M

Composition

Bilastine 20mg + Montelukast 10mg

Therapeutic Segment

Anti-allergic / Antihistamine

Pharmacological Action

Anti-allergic / Antihistamine

Mechanism

Bilastine blocks H1 histamine receptors reducing allergic symptoms, while Montelukast inhibits leukotriene receptors to reduce airway inflammation and allergic responses.

Key Clinical Benefits